Profil
Breian Knudsen formerly worked at Novo Nordisk A, as Manager and Veloxis Pharmaceuticals A, as Vice President-Technical Operations from 2007 to 2016.
Mr. Knudsen received his graduate degree from the University of Copenhagen.
Anciens postes connus de Breian Knudsen
| Sociétés | Poste | Fin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Directeur Technique/Scientifique/R&D | 01/05/2016 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formation de Breian Knudsen
| University of Copenhagen | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Entreprise privées | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
